Results 91 to 100 of about 10,379 (219)

Potential Suitability of Sulfadoxine-Pyrimethamine Plus Amodiaquine for Seasonal Malaria Chemoprevention in Areas of High, Pre-Existing Drug Resistance

, 2023
Christian Rassi, Monica Anna de Cola, Craig Bonnington, Gina Cuomo-Dannenburg, Andria Mousa, Sam Gudoi, K. Scott Baker, Ivan Alejandro Pulido Tarquino, Robert Verity, Matthew Cairns, Paul Milligan, Cally Roper, Lucy Okell, Patrick Walker, Maria Suau Sans, Chukwudi A Nnaji, John Baptist Bwanika   +16 more
openalex   +1 more source

Protective response to Sulfadoxine-pyrimethamine during intermittent presumptive treatment of malaria in pregnant women in Sagamu, Nigeria

, 2010
A. A. Adedeji, Ernest Tambo, Fatai A. Fehintola, Moyosola Similoluwa Akinwunmi, Olubukola Tikare, Oriola I. Mebude, Olusoji Jagun   +6 more
openalex   +2 more sources

Highly Efficient Sulfadoxine Aptasensors: From Polyaniline Probe to Potassium Ferricyanide Probe

Xiao‐Zhen Feng, Yu Ge, Fang-Li Chen, Zhencheng Chen, Guo‐Cheng Han, Heinz‐Bernhard Kraatz   +5 more
openalex   +1 more source

Antiplamodial effect of sulfadoxine/pyrimethamine/clindamycin: A study in parasitized mice

, 2022
Elias Adikwu, Joseph Igono, Confidence Orgechi NWORGU   +2 more
openalex   +2 more sources

Inequalities in the use of three-dose of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine among women in Sierra Leone, 2008-2019. [PDF]

Malar J
Osborne A, Bai-Sesay AU, Sesay U, Bangura C, Ahinkorah BO.   +4 more
europepmc   +1 more source

Disparate co-evolution and prevalence of sulfadoxine and pyrimethamine resistance alleles and haplotypes at dhfr and dhps genes across Africa [PDF]

Nina F. D. White, Georgia Whitton, Varanya Wasakul, Lucas Amenga–Etego, Antoine Dara, Voahangy Andrianaranjaka, Milijaona Randrianarivelojosia, Olivo Miotto, Umberto D’Alessandro, Abdoulaye Djimdé, Cristina V. Ariani, Richard D. Pearson, Alfred Amambua‐Ngwa   +12 more
openalex   +1 more source

Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in <i>Plasmodium berghei</i>-infected mice. [PDF]

Toxicol Rep
Olanlokun JO, Yahaya OO, Babarinde CO, Oloke OM, Steenkamp P, Prinsloo G.   +5 more
europepmc   +1 more source

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia. [PDF]

BMC Infect Dis
Martinez-Vega R, Chaponda M, Mousa A, Gwasupika J, Chaponda EB, Daka V, Mwanza S, Chipunga M, Beshir KB, Chopo-Pizarro A, Kaur H, Okell L, Hansson H, Hocke EF, Alifrangis M, Gosling R, Roper C, Sutherland C, Chico RM.   +18 more
europepmc   +1 more source

The impact of sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis. [PDF]

Lancet Infect Dis
van Eijk AM, Stepniewska K, Khairallah C, Rodriguez E, Ahn J, Gutman JR, Ter Kuile FO, IPTp-SP Effectiveness Study group.   +7 more
europepmc   +1 more source

Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in Africa. [PDF]

Sci Rep
Aliyu IA, Bala JA, Musa BM, Amole TG, Ahmed AB, Kovalenko G, Umar A, Garba Y, Gwarzo SA, Mansur A, Hidaya MG, Aliyu MH, Galadanci HS.   +12 more
europepmc   +1 more source